Ojjaara — Carefirst Caremark
4 indications indexed for this drug.
- High Risk Myelofibrosis With Anemia Or Symptomatic SplenomegView coverage criteria
- Intermediate Risk Myelofibrosis With AnemiaView coverage criteria
- Myelofibrosis Associated Anemia With Symptomatic SplenomegalView coverage criteria
- Symptomatic Accelerated Phase Or Blast Phase MyeloproliferatView coverage criteria